Broadridge Declares Quarterly Dividend Of $0.54 Per Share
NEW YORK, Nov. 15, 2019 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE: BR) announced that its Board of Directors has declared a quarterly cash dividend of $0.54 per share. The dividend is payable on January 3, 2020 to stockholders of record at the close of business on December 13, 2019.
About Broadridge Broadridge Financial Solutions, Inc. (NYSE: BR), a $4 billion global Fintech leader, is a leading provider of investor communications and technology-driven solutions to banks, broker-dealers, asset and wealth managers and corporate issuers. Broadridge's infrastructure underpins proxy voting services for over 50 percent of public companies and mutual funds globally, and processes on average more than U.S.$7 trillion in fixed income and equity securities trades per day. Broadridge is part of the S&P 500® Index and employs over 11,000 full-time associates in 18 countries.
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, announces the promotion of 93 distinguished experts across multiple practices and geographies. These well-deserved senior expert promotions span the firm's areas of...
Creative Group, a full-service meeting, incentive, and recognition agency, is thrilled to announce the resounding success of its clients' 2023 incentive programs, showcasing a remarkable return on investment and unprecedented participant engagement....
DWF Labs, a new generation Web3 investor, will be onboarding as Klaytn's latest Governance Council (GC) member, with their GC membership application having passed on-chain voting with 98% in favor. In a bold move to demonstrate their commitment to...
Today McLeod Software announced their enhanced solution for private fleet trucking operations, called LoadMaster Private Fleet. The solution is built on the company's proven LoadMaster Enterprise operations software, already used by dozens of private...
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...
